Baumgartner Jeffrey W 4
4 · CIRRUS LOGIC, INC. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Baumgartner Jeffrey W
EVP, R&D
Transactions
- Exercise/Conversion
Common Stock
2025-09-17$78.00/sh+7,308$570,024→ 21,309 total - Exercise/Conversion
Common Stock
2025-09-17$88.00/sh+1,000$88,000→ 15,001 total - Sale
Common Stock
2025-09-17$120.00/sh−1,000$120,000→ 14,001 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-17−1,000→ 5,408 totalExercise: $88.00Exp: 2032-03-02→ Common Stock (1,000 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2025-09-17−854→ 1,026 totalExercise: $78.00Exp: 2031-03-03→ Common Stock (854 underlying) - Sale
Common Stock
2025-09-17$120.00/sh−7,308$876,960→ 14,001 total - Sale
Common Stock
2025-09-17$120.00/sh−854$102,480→ 14,001 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-17−7,308→ 368 totalExercise: $78.00Exp: 2031-03-03→ Common Stock (7,308 underlying) - Exercise/Conversion
Common Stock
2025-09-17$78.00/sh+854$66,612→ 14,855 total
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.
- [F2]Only vested shares can be exercised under this option. 25% of the shares vested on 3/3/22; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 3/3/25.
- [F3]Only vested shares can be exercised under this option. 25% of the shares vested on 3/2/23; the remaining shares will vest monthly over the following 36 months so that the option will be fully vested and exercisable on 3/2/26.